{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:45:14Z","timestamp":1782827114441,"version":"3.54.5"},"reference-count":58,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"unspecified","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["-DOI 10.55776\/ESP138"],"award-info":[{"award-number":["-DOI 10.55776\/ESP138"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["-DOI 10.55776\/FG25"],"award-info":[{"award-number":["-DOI 10.55776\/FG25"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["-DOI 10.55776\/T737"],"award-info":[{"award-number":["-DOI 10.55776\/T737"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["-DOIs 10.55776\/P27001"],"award-info":[{"award-number":["-DOIs 10.55776\/P27001"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/DOC82"],"award-info":[{"award-number":["10.55776\/DOC82"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/P33855"],"award-info":[{"award-number":["10.55776\/P33855"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/PAT5895324"],"award-info":[{"award-number":["10.55776\/PAT5895324"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001822","name":"\u00d6sterreichischen Akademie der Wissenschaften","doi-asserted-by":"publisher","award":["DOC\/26015"],"award-info":[{"award-number":["DOC\/26015"]}],"id":[{"id":"10.13039\/501100001822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,6,7]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Metabolic competition and nutrient restriction in the tumor microenvironment (TME) shape the immune infiltrate in tumors and subsequently tumor immunity. In this study we used the transgenic melanoma mouse model tg(Grm1)EPv, which spontaneously develops melanoma due to the ectopic expression of the metabotropic glutamate receptor 1 (\n                      <jats:italic>Grm1<\/jats:italic>\n                      ) in melanocytes to investigate if aberrant glutamate metabolism drives tumor formation and affects immune cell function.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed liquid chromatography-tandem mass spectrometry (LC-MS\/MS)-based metabolomic analyses and RNA sequencing on tumor-free and tumor-bearing tg(Grm1)EPv tissues to characterize metabolic alterations associated with tumor progression. Flow cytometry was used to examine changes in immune cell subsets within the TME. To assess the functional relevance of glutamate metabolism, we inhibited glutathione metabolism using L-buthionine-(S,R)-sulfoximine (BSO), an inhibitor of glutamate-cysteine ligase that depletes cellular glutathione levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>LC-MS\/MS-based metabolomic analyses and RNA sequencing revealed changes in glutamate and glutamine metabolism, a glycolytic shift (Warburg effect), and reduced ATP levels in advanced tumors compared with tumor-free tissue, suggesting respiratory chain dysfunction. These metabolic changes in the TME are advantageous for the tumor cells and unfavorable for immune cells, such as dendritic cells (DC). Indeed, flow cytometry analysis of myeloid subsets during tumor progression showed a decline in tumor-infiltrating conventional type 2 DC and macrophages, alongside an increase in neutrophil and monocyte populations in advanced lesions. Interference with glutamate metabolism using BSO induced immunogenic cell death, namely ferroptosis, in an tg(Grm1)EPv-derived cell line in vitro. Therefore, we evaluated the combination of this inhibitor with immunotherapy as a promising new approach for the treatment of tumors in the tg(Grm1)EPv mouse model. We observed that tumor growth could be delayed in vivo when BSO was combined with a therapy regimen boosting DC numbers and activation. This inhibition of tumor growth was supported by the infiltration of activated T cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, our findings provide novel insights into the importance of combining metabolic intervention with immunotherapy for the treatment of patients with melanoma, particularly those bearing glutamate pathway-active or immunologically cold tumors. This knowledge can drive the design of novel therapeutic strategies for patients with cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2026-014808","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:56:49Z","timestamp":1782824209000},"page":"e014808","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanoma"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9680-7620","authenticated-orcid":false,"given":"Sophie Marie","family":"Dieckmann","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5502-7241","authenticated-orcid":false,"given":"Christoph H","family":"Tripp","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Strandt","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Hornsteiner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Austria"},{"name":"Tyrolean Cancer Research Institute, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelie Kerstin","family":"Sch\u00e4fer","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6009-9335","authenticated-orcid":false,"given":"Anastasia","family":"Prokopi","sequence":"additional","affiliation":[{"name":"Centre for Immunobiology and Infection, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Vierthaler","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venerelogoy and Allergology, Medical University of Innsbruck University Hospital for Dermatology and Venereology, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Resag","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Dresden University of Technology, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ortner-Tobider","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Reinstadler","sequence":"additional","affiliation":[{"name":"Institute of Legal Medicine and Core Facility Metabolomics, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Rigato","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit","family":"Junger","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexeja","family":"Kleiter","sequence":"additional","affiliation":[{"name":"Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Fotakis","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Efremova","sequence":"additional","affiliation":[{"name":"Barts Cancer Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zlatko","family":"Trajanoski","sequence":"additional","affiliation":[{"name":"Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Boon","sequence":"additional","affiliation":[{"name":"JJP Biologics, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzie","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Chemical Biology, Rutgers The State University of New Jersey, New Brunswick, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja Katrin","family":"Bosserhoff","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry, FAU, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Oberacher","sequence":"additional","affiliation":[{"name":"Institute of Legal Medicine and Core Facility Metabolomics, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Finotello","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Stoitzner","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"2026063005501806000_14.6.e014808.1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060"},{"key":"2026063005501806000_14.6.e014808.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.03.030"},{"key":"2026063005501806000_14.6.e014808.3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00400"},{"key":"2026063005501806000_14.6.e014808.4","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1059"},{"key":"2026063005501806000_14.6.e014808.5","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-20-0430"},{"key":"2026063005501806000_14.6.e014808.6","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3665"},{"key":"2026063005501806000_14.6.e014808.7","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2023.100960","article-title":"A 211At-labelled mGluR1 inhibitor induces cancer senescence to elicit long-lasting anti-tumor efficacy","volume":"4","author":"Xie","year":"2023","journal-title":"Cell Rep Med"},{"key":"2026063005501806000_14.6.e014808.8","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23455"},{"key":"2026063005501806000_14.6.e014808.9","doi-asserted-by":"publisher","DOI":"10.1038\/ng1148"},{"key":"2026063005501806000_14.6.e014808.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.02.011"},{"key":"2026063005501806000_14.6.e014808.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2005.10.012"},{"key":"2026063005501806000_14.6.e014808.12","doi-asserted-by":"crossref","DOI":"10.3390\/cells11182857","article-title":"Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression","volume":"11","author":"Eddy","year":"2022","journal-title":"Cells"},{"key":"2026063005501806000_14.6.e014808.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2017.06.003"},{"key":"2026063005501806000_14.6.e014808.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.08.014"},{"key":"2026063005501806000_14.6.e014808.15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00534","article-title":"Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses","volume":"6","author":"Clausen","year":"2015","journal-title":"Front Immunol"},{"key":"2026063005501806000_14.6.e014808.16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-56392-x","article-title":"MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma","volume":"16","author":"Niveau","year":"2025","journal-title":"Nat Commun"},{"key":"2026063005501806000_14.6.e014808.17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1795"},{"key":"2026063005501806000_14.6.e014808.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.025"},{"key":"2026063005501806000_14.6.e014808.19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.10.6695"},{"key":"2026063005501806000_14.6.e014808.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0626-z"},{"key":"2026063005501806000_14.6.e014808.21","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1038\/jid.2015.241","article-title":"Impaired gp100-Specific CD8(+) T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma Model","volume":"135","author":"Mairhofer","year":"2015","journal-title":"J Invest Dermatol"},{"key":"2026063005501806000_14.6.e014808.22","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000832","article-title":"Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy","volume":"9","author":"Prokopi","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2026063005501806000_14.6.e014808.23","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1111\/cas.14182","article-title":"Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma","volume":"110","author":"Okazaki","year":"2019","journal-title":"Cancer Sci"},{"key":"2026063005501806000_14.6.e014808.24","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.22625"},{"key":"2026063005501806000_14.6.e014808.25","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12220"},{"key":"2026063005501806000_14.6.e014808.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0439-x"},{"key":"2026063005501806000_14.6.e014808.27","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4197"},{"key":"2026063005501806000_14.6.e014808.28","doi-asserted-by":"crossref","unstructured":"Zhou Y , Zhou B , Pache L , et al . Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 2019;10. doi:10.1038\/s41467-019-09234-6","DOI":"10.1038\/s41467-019-09234-6"},{"key":"2026063005501806000_14.6.e014808.29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.282046"},{"key":"2026063005501806000_14.6.e014808.30","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.198"},{"key":"2026063005501806000_14.6.e014808.31","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-025-02141-x","article-title":"Energy metabolism in health and diseases","volume":"10","author":"Liu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"2026063005501806000_14.6.e014808.32","doi-asserted-by":"publisher","DOI":"10.1002\/EJI.202250004"},{"key":"2026063005501806000_14.6.e014808.33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41577-024-01079-5","article-title":"Striking a balance: new perspectives on homeostatic dendritic cell maturation","volume":"25","author":"Bosteels","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"2026063005501806000_14.6.e014808.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2008.00452.x"},{"key":"2026063005501806000_14.6.e014808.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(97)10071-3"},{"key":"2026063005501806000_14.6.e014808.36","doi-asserted-by":"publisher","DOI":"10.1124\/mol.59.5.965"},{"key":"2026063005501806000_14.6.e014808.37","doi-asserted-by":"crossref","first-page":"117785","DOI":"10.1016\/j.biopha.2024.117785","article-title":"DLBCL cells with ferroptosis morphology can be detected with a deep convolutional neural network","volume":"182","author":"Kotkaranta","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"2026063005501806000_14.6.e014808.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2014.12.006"},{"key":"2026063005501806000_14.6.e014808.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-00324-8"},{"key":"2026063005501806000_14.6.e014808.40","doi-asserted-by":"crossref","unstructured":"Wiernicki B , Maschalidi S , Pinney J , et al . Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nat Commun 2022;13. doi:10.1038\/s41467-022-31218-2","DOI":"10.1038\/s41467-022-31218-2"},{"key":"2026063005501806000_14.6.e014808.41","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/s41418-025-01517-4","article-title":"An atlas of ferroptosis-induced secretomes","volume":"32","author":"Yapici","year":"2025","journal-title":"Cell Death Differ"},{"key":"2026063005501806000_14.6.e014808.42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0360-3016(94)90298-4","article-title":"Selective toxicity of buthionine sulfoximine (BSO) to melanoma cells in vitro and in vivo","volume":"29","author":"R\u00e9v\u00e9sz","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026063005501806000_14.6.e014808.43","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.14"},{"key":"2026063005501806000_14.6.e014808.44","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023668705040"},{"key":"2026063005501806000_14.6.e014808.45","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2012.0159"},{"key":"2026063005501806000_14.6.e014808.46","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf1119"},{"key":"2026063005501806000_14.6.e014808.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.01.004"},{"key":"2026063005501806000_14.6.e014808.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.04.010"},{"key":"2026063005501806000_14.6.e014808.49","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06299-8"},{"key":"2026063005501806000_14.6.e014808.50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.1997.tb00490.x"},{"key":"2026063005501806000_14.6.e014808.51","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.7150\/thno.105276","article-title":"Metabolic regulation of myeloid-derived suppressor cells in tumor immune microenvironment: targets and therapeutic strategies","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"key":"2026063005501806000_14.6.e014808.52","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-024-03220-9","article-title":"Melanoma biology and treatment: a review of novel regulated cell death-based approaches","volume":"24","author":"Hsieh","year":"2024","journal-title":"Cancer Cell Int"},{"key":"2026063005501806000_14.6.e014808.53","first-page":"2327","article-title":"Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine","volume":"49","author":"Kable","year":"1989","journal-title":"Cancer Res"},{"key":"2026063005501806000_14.6.e014808.54","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.cell.2025.12.002","article-title":"Extracellular GPX4 impairs antitumor immunity via dendritic ZP3 receptors","volume":"189","author":"Liu","year":"2026","journal-title":"Cell"},{"key":"2026063005501806000_14.6.e014808.55","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001369","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity","volume":"8","author":"Efimova","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2026063005501806000_14.6.e014808.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.016"},{"key":"2026063005501806000_14.6.e014808.57","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.43"},{"key":"2026063005501806000_14.6.e014808.58","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.jid.2023.03.1664","article-title":"A Spontaneous Melanoma Mouse Model Applicable for a Longitudinal Chemotherapy and Immunotherapy Study","volume":"143","author":"Eddy","year":"2023","journal-title":"J Invest Dermatol"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-014808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:57:00Z","timestamp":1782824220000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-014808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":58,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,30]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/jitc-2026-014808"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-014808","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}